Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,729,088
New position
Shares Held
527,800
first reported quarter
Ownership
0.313%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Empyrean Capital Partners, LP holds $14,687,488 across 2 Biotechnology names. VIR ranks #2 (32.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
102,400 | $9,958,400 | |
| 2 | VIR |
Vir Biotechnology, Inc.
This page
|
527,800 | $4,729,088 |
All Filings in VIR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,729,088 | 527,800 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||